posted on 2025-05-09, 10:52authored byImmaculata De Vivo, Jennifer Prescott, Linda S. Cook, Marta Crous-Bou, Jennifer Doherty, Alison M. Dunning, Douglas F. Easton, Christine M. Friedenreich, Montserrat Garcia-Closas, Mia M. Gaudet, Christopher Haiman, Susan E. Hankinson, Veronica Wendy Setiawan, Patricia Hartge, Brian E. Henderson, Elizabeth HollidayElizabeth Holliday, Pamela L. Horn-Ross, David J. Hunter, Loic Le Marchand, Xiaolin Liang, Jolanta Lissowska, Jirong Long, Lingeng Lu, Sara H. Olson, Anthony M. Magliocco, Mark McEvoyMark McEvoy, Tracy A. O'Mara, Irene Orlow, Jodie N. Painter, Loreall Pooler, Radhai Rastogi, Timothy R. Rebbeck, Harvey Risch, Carlotta Sacerdote, Nicolas Wentzensen, Frederick Schumacher, Rodney ScottRodney Scott, Xin Sheng, Xiao-ou Shu, Amanda B. Spurdle, Deborah Thompson, David VanDen Berg, Noel S. Weiss, Lucy Xia, Yong-Bing Xiang, John AttiaJohn Attia, Hannah P. Yang, Herbert Yu, Wei Zheng, Stephen Chanock, Peter Kraft, Amanda Black, Louise Brinton, Chu Chen, Constance Chen
Endometrial cancer (EC), a neoplasm of the uterine epithelial lining, is the most common gynecological malignancy in developed countries and the fourth most common cancer among US women. Women with a family history of EC have an increased risk for the disease, suggesting that inherited genetic factors play a role. We conducted a two-stage genome-wide association study of Type I EC. Stage 1 included 5,472 women (2,695 cases and 2,777 controls) of European ancestry from seven studies. We selected independent single-nucleotide polymorphisms (SNPs) that displayed the most significant associations with EC in Stage 1 for replication among 17,948 women (4,382 cases and 13,566 controls) in a multiethnic population (African America, Asian, Latina, Hawaiian and European ancestry), from nine studies. Although no novel variants reached genome-wide significance, we replicated previously identified associations with genetic markers near the HNF1B locus. Our findings suggest that larger studies with specific tumor classification are necessary to identify novel genetic polymorphisms associated with EC susceptibility.